Antiproliferative effects of 13α/β-steroids on triple-negative MDA-MB-231 breast cancer cells: unraveling intracellular signaling without ERα
Alexander M. Scherbakov(Gause Institute of New Antibiotics Russian Academy of Medical Sciences), И. С. Левина(Russian Academy of Sciences)
Cited by 6
Related Papers
Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells
|Frontiers in Pharmacology|2018|65
The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
|IUBMB Life|2016|60
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells
|Investigational New Drugs|2023|29
Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance
|Cancer Drug Resistance|2023|18
Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin
|Research in Pharmaceutical Sciences|2023|10